May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Laser Subepithelial Keratomileusis (LASEK): post–operative pain and epithelial healing with topical 0.1% Indomethacin or 0.1% Fluorometholon acetate eye drops
Author Affiliations & Notes
  • F. Badalà
    Clinica Oculistica, Università di Genova, Genova, Italy
  • S. Giuffrida
    Research Laboratories, Bausch&Lomb Oftal, Catania, Italy
  • M. Fioretto
    Ophthalmology, Casale Monferrato Hospital, Alessandria, Italy
    Ophthalmology, MEDVISION Eye Clinic, Alessandria, Italy
  • V. Amico
    Research Laboratories, Bausch&Lomb Oftal, Catania, Italy
  • M. Cro
    Research Laboratories, Bausch&Lomb Oftal, Catania, Italy
  • A. Macrì
    Ophthalmology Unit, San Martino Hospital, Genova, Italy
  • Footnotes
    Commercial Relationships  F. Badalà, None; S. Giuffrida, Bausch&Lomb Oftal E; M. Fioretto, None; V. Amico, Bausch&Lomb Oftal E; M. Cro, Bausch&Lomb Oftal E; A. Macrì, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 168. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      F. Badalà, S. Giuffrida, M. Fioretto, V. Amico, M. Cro, A. Macrì; Laser Subepithelial Keratomileusis (LASEK): post–operative pain and epithelial healing with topical 0.1% Indomethacin or 0.1% Fluorometholon acetate eye drops . Invest. Ophthalmol. Vis. Sci. 2004;45(13):168.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To compare postoperative pain and epithelial healing after LASEK surgery using topical 0.1 % Indomethacin eye drops or 0.1% Fluorometholon acetate eye drops. Methods: Prospective, randomised, double–masked clinical trial on 159 patients (age between 24 and 40 years, refractive error between –2 and –6.50D) undergoing LASEK. Patients were randomly divided into two groups. Group 1 of 80 patients (mean age 29±3 years) received 0.1% Indomethacin eye drops (Indocollirio®, Bausch&Lomb Oftal, Catania, Italy) QID, while Group 2 (79 patients, mean age 29 ±4 years) received 0.1% Fluorometholon eye drops (Flarex® , Alcon Italia, Milan, Italy) QID. Patients were evaluated 2–4 days before (T0) and 4 days after surgery (T1). Corneal fluorescein staining (score from 0 to 3 for each of the four quadrant considered), corneal aesthesiometry (Cochet–Bonnet aesthesiometer, Luneau, France) and the level of pain (according to an analogic visual scale from 0 to 10) were evaluated at T0 and T1. In addition haze was evaluated at 14+1 weeks after surgery using Fantes classification (Arch. Ophthalmol., 1990). Results: At T1 pain level was 2.02±2.01 (mean ± standard deviation) in the Indomethacin group and 6.12± 1.51 in the Fluorometholon group (p<0.0001, Mann Whitney U–test); corneal fluorescein staining was 1.40±1.26 in the Indomethacin group and 4.04±2.73 in the Fluorometholon group (p<0.0001, Mann Whitney U–test). Corneal aesthesiometry was reduced to the same extent in both groups. At T1 it was 4.45±0.60 in the Indomethacin group and 4.85±0.82 in the Fluorometholon group in comparison with T0 values of 5.92±0.20 and 5.98±0.15 respectively. Haze did not differ significantly between the two groups 14 weeks after surgery. Conclusions: Our study suggests that less pain and a faster epithelial healing process are associated with the use of 0.1% Indomethacin eye drops as compared to 0.1%Fluorometholon eye drops in patients undergoing LASEK surgery.

Keywords: refractive surgery: comparative studies • wound healing • pharmacology 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×